SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Nancy: One year suspended prison sentence required against caregivers after the death of young Timéo at the CHRU Nov 23, 2022
- How the Aisne and the Oise protect themselves from floods and floods that were once devastating Nov 21, 2022
- Warframe continues to demonstrate why it is such a popular shooter with its new expansion: trailer and details Jul 19, 2021
- Natterjack toad and sand lizard lose out to grandstands on circuit in Zandvoort, but will F1 continue? Aug 12, 2021
- Twitter: Elon Musk Reinstates Donald Trump’s Account Nov 20, 2022
- Users can permanently lose their Whatsapp account; understand Apr 14, 2021
- “Unconventional thinker” storms the stage: Armin Laschet remains calm – Lauterbach expresses fierce criticism Sep 6, 2021